Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BeyondSpring Inc.    BYSI   KYG108301006

BEYONDSPRING INC.

(BYSI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about BEYONDSPRING INC.
08/11BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients S..
GL
06/30New Stem Cell-Based Application for BeyondSpring's Plinabulin Presented at IS..
GL
06/25BEYONDSPRING : 2020 First Quarter Financial Report
PU
06/23New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Comb..
GL
06/19BeyondSpring Announces Pricing of Ordinary Shares
GL
06/18BeyondSpring Announces Proposed Public Offering of Ordinary Shares
GL
06/11BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Upd..
GL
06/09BeyondSpring's PROTECTIVE-2 (Study 106) Phase 2 Trial for Chemotherapy-Induce..
GL
06/03BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plin..
GL
06/02BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program
GL
05/20BEYONDSPRING INC. : quaterly earnings release
05/13BeyondSpring Granted New U.S. Patent for Plinabulin to Treat Severe Chemother..
GL
04/30BEYONDSPRING : Study 106 Phase 2 Summary
PU
04/30BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and ..
GL
04/29CORRECTION – FDA Submission to Change the Primary Endpoint into an Indu..
GL
More most relevant news
All news about BEYONDSPRING INC.
08/11BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients S..
GL
06/30New Stem Cell-Based Application for BeyondSpring's Plinabulin Presented at IS..
GL
06/25BEYONDSPRING : 2020 First Quarter Financial Report
PU
06/23New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Comb..
GL
06/19BeyondSpring Announces Pricing of Ordinary Shares
GL
06/18BeyondSpring Announces Proposed Public Offering of Ordinary Shares
GL
06/11BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Upd..
GL
06/09BeyondSpring's PROTECTIVE-2 (Study 106) Phase 2 Trial for Chemotherapy-Induce..
GL
06/03BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plin..
GL
06/02BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program
GL
More news
News in other languages on BEYONDSPRING INC.
08/11BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients S..
06/30New Stem Cell-Based Application for BeyondSpring's Plinabulin Presented at IS..
06/25BEYONDSPRING : 2020 First Quarter Financial Report
06/23New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Comb..
06/19BeyondSpring Announces Pricing of Ordinary Shares
06/18BeyondSpring Announces Proposed Public Offering of Ordinary Shares
06/11BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Upd..
06/09BeyondSpring's PROTECTIVE-2 (Study 106) Phase 2 Trial for Chemotherapy-Induce..
06/03BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plin..
06/02BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program
Press releases
08/11BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients S..
GL
06/30New Stem Cell-Based Application for BeyondSpring's Plinabulin Presented at IS..
GL
06/25BEYONDSPRING : 2020 First Quarter Financial Report
PU
06/23New Preclinical Data Demonstrates Immune-Enhancing Effects of Triple I/O Comb..
GL
06/19BeyondSpring Announces Pricing of Ordinary Shares
GL
More press releases
Upcoming event on BEYONDSPRING INC.